Maternal Serum Isthmin-1 as a Novel Biomarker for Late-Onset Fetal Growth Restriction
Özge Öztürk, Recep Taha Ağaoğlu, Gunel Aliyeva, Mesut Şimşek, Kadriye Yakut Yücel · 2026
Read Maternal Serum Isthmin-1 as a Novel Biomarker for Late-Onset Fetal Growth Restriction by Özge Öztürk, Recep Taha Ağaoğlu, Gunel Aliyeva, Mesut Şimşek, Kadriye Yakut Yücel (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13607117.txt.
Description
Özge Öztürk and four co-authors reported a 2026 study on a blood protein that might flag poor fetal growth late in pregnancy. Growth restriction means a baby grows more slowly than expected before birth. The team compared forty-four women whose babies had late-onset growth problems with forty-three healthy controls of the same stage. Blood levels of the protein were measured with a standard lab test.
Levels were lower in the group with growth problems, and lower levels went with a higher chance of the condition. As a test on its own, though, the protein was only fair at telling the two groups apart. It also showed no link to poor outcomes after birth. The authors call it a hopeful early lead that needs more study, not a stand-alone test.
Catalog record
| CREATOR | Özge Öztürk, Recep Taha Ağaoğlu, Gunel Aliyeva, Mesut Şimşek, Kadriye Yakut Yücel |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |